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Interactions of low density lipoprotein with rat inesangial cells. Hyper-
lipidemia may contribute to the pathogenesis of glomerular sclerosis.
We therefore studied binding and uptake of low density lipoprotein
(LDL) by cultured rat mesangial cells. In addition effects of LDL on
POE2 synthesis and cell proliferation were determined. At 4°C mesan-
gial cells bound [12511 LDL in a time- and concentration-dependent
manner with half-maximal binding observed at 5 jtg/ml of LDL protein.
Binding was blocked by excess unlabeled LDL and by heparin. Uptake
(binding plus internalization) of LDL at 37°C markedly exceeded
binding at 4°C, continued to increase even with longer periods of
incubation, and showed no saturability, consistent with uptake of LDL
by mesangial cells. Further evidence for LDL uptake by mesangial cells
was obtained by use of the fluorescent probe 1,1 -dioactadecyl-3,3,3',
3'-tetramethylindocarbocyanine perchiorate-labeled LDL (Dil-LDL).
Incubation of mesangial cells with Dil-LDL at 37°C showed positive
fluorescence for all mesangial cells, indicating uptake of the Dil-LDL.
LDL had a biphasic effect on mesangial cell proliferation as determined
by [3H] thymidine incorporation. LDL at 10 tg/ml enhanced [3H1
thymidine uptake modestly, but significantly, whereas a progressive
and marked inhibition occurred at LDL concentrations from 100 to 500
tg/ml. While LDL at 10 and 100 gg/ml significantly stimulated POE2
production, inhibition of POE2 by meclofenamate did not influence the
effects of LDL on [3H} thymidine incorporation. We conclude that
mesangial cells show specific binding and uptake of LDL and that high
concentrations of LDL markedly decrease mesangial cell proliferation.
These findings may pertain to the pathogenesis of glomerular lesions in
hyperlipidemia of renal disease.
A variety of abnormalities in lipid metabolism are observed in
mammals with natural and experimental renal diseases [1, 2].
For example, glomerular injury is characterized by an increase
in lipoprotein synthesis and a decrease in peripheral lipoprotein
catabolism [1—51. These abnormalities often lead to marked
increases in total plasma cholesterol concentrations, particu-
larly very low-density lipoprotein and low-density lipoprotein
(LDL) fractions [1, 21. It has been proposed that this hyperlip-
idemia may contribute to progression of the glomerular lesion
long after the original insult [6, 7]. Maneuvers that alter serum
lipids influence glomerular function and morphology in the 5/6
nephrectomized rat [8], in the obese Zucker rat [9] and in the
focal sclerosis developing in the puromycin aminonucleoside
nephrosis model [101. As in systemic atherosclerosis, enhanced
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local lipoprotein accumulation may be a pathogenetic factor for
the glomerular lesions [6, 7, 11].
Many cell types, including fibroblasts, vascular smooth mus-
cle cells, and endothelial cells demonstrate receptor mediated
endocytosis of LDL [12]. A recent abstract also reported LDL
binding to mesangial cells [13]. In addition, in vitro studies have
shown that LDL can influence proliferation of smooth muscle
and endothelial cells in a biphasic manner: low concentrations
of LDL support cell growth, whereas higher concentrations are
toxic [14—16]. If mesangial cells possess LDL receptors like
vascular smooth muscle cells, they too could accumulate and be
injured by high concentrations of LDL.
We therefore examined LDL binding and uptake to mesangial
cells and the resulting effect on mesangial cell proliferation. Our
study demonstrates that mesangial cells show typical LDL
binding and that high concentrations of LDL are toxic to
mesangial cells, findings which may be of interest for glomeru-
lar injury in hyperlipidemia.
Methods
Materials
[12311 sodium, (carrier free in NaOH) and [3H] thymidine were
obtained from Amersham, Arlington Heights, Illinois, USA.
Fatty acid free bovine serum albumin was from Sigma Chemical
Co., (St. Louis, Missouri, USA) and heparin (sodium salt, 200
units/mg) from Lypho Med Inc. (Rosemont, Illinois, USA).
Eagle's minimum essential medium, RPMI 1460 penicillin (0.66
jtg/ml)-streptomycin (60 ,ag/ml) solution, fetal calf serum, Nu-
serum and Dulbecco's phosphate buffered saline were pur-
chased from Gibco Laboratories, (Grand Island), New York,
USA. Tissue culture flasks, six-, 24- and 96-well culture plates
were purchased from Corning Laboratories, Corning, New
York, USA, Enzymobeads were purchased from Biorad, Rich-
mond, California, USA. LDL labeled with 1,1 '-dioactadecyl-
3,3,3' ,3 '-tetramethylindocarbocyanine perchlorate (Dil-LDL)
was from Biomedical Technologies Inc., Stoughton, Massachu-
setts, USA.
Glomerular isolation and culture of mesangial cells
Male Sprague-Dawley rats (Charles River Breeders, Wil-
mington, Massachusetts, USA) were maintained on tap water
and Purina rat chow ad libitum. Kidneys were removed under
pentobarbital anesthesia. The glomeruli were isolated and cul-
tured as previously described [17]. The culture medium con-
sisted of RPMI 1640 supplemented with 10% fetal calf serum,
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penicillin and streptomycin. After mesangial cells had reached
confluence (15 to 20 days after glomerular seeding) they were
subcultured according to previously published methods [17].
Mesangial cells were used after three to five subcultures.
Preparation and labeling of lipoproteins
were fractionated by sequential flotation in a Beckman prepar-
ative ultracentrifuge at 15°C for 18 hours according to standard
techniques using solid KBrfor density adjustment [18]. Isolated
LDL was dialyzed for 24 hours at 4°C against three changes of
at least 1000 volumes of phosphate buffered saline, pH 7.4,
containing penicillin and streptomycin.
[12sJj LDL was prepared using enzymobeads, an immobilized
preparation of lactoperoxidase and glucose oxidase (Biorad).
Labeled LDL was separated from free [125Jj by desalting
column chromatography (Biorad), and dialyzed 24 hours
against three changes of 4000 volumes of PBS. Final specific
activities of the [12511 LDL ranged from 106 to l0 CPM per g
of LDL protein. The [125J] LDL was stored at 4°C and used for
binding experiments within 10 hours of iodination.
'251LDL binding to mesangial cells
.4...',
Confluent mesangial cells in six or 24 well plates were
maintained for 36 hours prior to experiments in medium con-
taining lipoprotein deficient serum consisting of DMEM plus
1% fetal calf serum, 8% Nu-serum and 1% pen-strep. The media
were then removed from each well and replaced with 1 ml of
medium consisting of Dulbecco's phosphate buffered saline
with 100 mg% glucose, 2 mg/mi BSA and [1251] LDL (106 CPM/
ml), and the additions indicated in Results. After incubation at
4°C to study binding or at 37°C to study uptake (binding plus
internalization) of LDL for the times indicated the medium was
removed and all subsequent procedures were carried out at 4°C.
Each well was washed three times with 2 ml of ice-cold 1%
bovine serum albumin PBS solution followed by another 2 ml of
the same solution, which was left for five minutes and then
removed. A final wash consisted of ice cold PBS without BSA.
The cells in the culture dishes were dissolved by a 12 hour
incubation with 2 ml of 1.0 N NaOH, and collected together
with a 2 ml wash of a 1% BSA-PBS solution for radioactivity
determination in a gamma counter. Aliquots of the cellular
protein dissolved in NaOH were used for protein determination
by the Bradford method.
LDL uptake by fluorescence microscopy
To further evaluate if all mesangial cells take up LDL we
used the fluorescence probe Dil-LDL [19]. Mesangial cells were
grown on 4-well plastic slides, washed and incubated in Dul-
becco's phosphate buffered saline with 100 mg% glucose and 10
p.g/ml of I)il-LDL at 37°C for two hours. After repeated
washings the cells were examined with a Zeiss inverted fluo-
rescence microscope and photographed.
Effects of LDL on mesangial cell proliferation
Cells were plated in 96 well plates at approximately 20,000
cells/mi and grown in RPMI with 10% FCS for five days. Media
were removed and replaced for 24 hours by lipoprotein deficient
media (as above). This was then replaced by the same, fresh
medium containing 1 pCiIml of [3H] thymidine and the experi-
mental agents (LDL, FCS, meclofenamate) as indicated in
Results. [3H] thymidine incorporation into DNA was deter-
mined after 24 hours of culture using a Mash harvester and
scintillation counting. All experiments were carried out in
triplicate or quadruplicate and the means of these served as a
single experiment.
Effect of LDL on PGE2 synthesis by mesangial cells
Mesangial cells were grown in 24 well plates and maintained
in lipoprotein-deficient medium for 24 hours prior to study as
detailed above. They were then incubated for 24 hours in the
same medium additions as listed in Results and PGE2 content
of the media were determined by enzyme immunoassay as
previously described by our laboratory [17].
Results
LDL binding to mesangial cells at 4°C
Initially we evaluated the time course of binding of [125!]
labeled LDL to cultured rat mesangial cells at 4°C. As shown in
Figure 1, binding of [125!] LDL to mesangial cells reached
equilibrium after about one hour of incubation. Addition of
excess (100 p.g/ml) unlabeled LDL resulted in a time-dependent
displacement of about 50% of the bound [12511 LDL, (Fig. 1).
The only 50% displacement of previously bound [12511 LDL by
unlabeled LDL is consistent with similar observations in other
systems [121. The binding affinity of [125J] LDL to mesangial
cells was studied by increasing the concentrations of unlabeled
LDL in the presence of constant amounts of [12511 labeled LDL
during two hour incubations at 4°C (Fig. 2). Binding occurred in
a saturable manner with half-maximal binding observed at
about 5 jg/ml of LDL. Estimation of the number of LDL
particles (assuming a molecular weight of 3 x 106) bound per
cell at 4°C yields about 1000 particles per cell. Both the binding
affinity and the number of binding sites per mesangial cell
Human LDL (dl.019 to 1.063 g per ml) was prepared from
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Fig. 1. Time course of binding and displacement of [125jj LDL to
mesangial cells. Mesangial cells were incubated with [12511 LDL (1 g/
ml) at 4°C and binding determined at the times indicated as described in
Methods. To some wells 100 jsg/ml of unlabeled LDL was added (closed
symbols) after two hours (arrow), while controls received vehicle only
(open triangle). The amount of bound [1251] LDL was then evaluated for
an additional two hours. Values represents means SEM of a duplicate
experiment and are expressed per 100 g of cellular protein.
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Fig. 2. Binding curve for increasing concentra lions of ['25J] LDL to
mesangial cells. Mesangial cells were incubated with [12511 LDL and
increasing concentrations of unlabeled LDL for 2 hours at 4°C; binding
per 100 jsg cell protein was determined as described in Methods, Results
are mean 5EM of one of two comparable experiments, each carried



























Fig. 3. Effect of heparin on cell-associated P25Jj LDL during incuba-
lions at 4° or 37°C. Binding of [1251] LDL in the presence or absence of
heparin sulfate (2 mg/mI) was evaluated after 2 hours of incubation at
4°C and binding uptake after 1 hour at 37°C. Results are mean 5EM of
duplicate experiments and are expressed per 100 ig of cellular protein.
closely approximate those reported by others for fibroblasts and
smooth muscle cells [121.
Heparin has been shown to inhibit LDL binding to its
receptor [20]. We therefore examined the effect of the simulta-
neous presence of heparin (2 mg/mI) on [125JJ LDL binding to
mesangial cells. As shown in Figure 3A, heparin blocked [125J]
binding at 4°C by over 80%, indicating that most of the LDL
binding to mesangial cells is receptor mediated.
LDL uptake by mesangial cells at 37°C
Next we examined [125j] LDL uptake by mesangial cells at
37°C, which would represent both binding and internalization.
Mesangial cells accumulated [125J] LDL progressively up to at














FIg. 4. Time course of bindiug and internalization of f'251j LDL by
meson gial cells at 37°C. Mesangial cells were incubated at 37°C with
[12511 LDL (1 .tg/ml) for the indicated times and uptake was evaluated.



















Fig. 5. Concentration-dependent binding and internalization of ['251j
LDL to meson gial cells. Mesangial cells were incubated with [1251] LDL
and increasing concentrations of unlabeled LDL for 2 hours at 37°C.
Each value represents the mean 5CM of duplicate experiments.
bound and internalized [125!] LDL as heparin caused a lesser
degree of inhibition of [125!] LDL at 37°C (Fig. 3B) as compared
to 4°C (Fig. 3A). LDL internalized by mesangial cells would not
be displaceable by heparin. Incubation of mesangial cells at
37°C with increasing concentrations of LDL for two hours did
not result in a typical saturation binding curve as observed at
4°C (Fig. 2), but rather showed progressive uptake of LDL even
at concentrations of 100 p.g/ml (Fig. 5). Also the amount of LDL
associated with mesangial cells after incubations at 37°C (Fig. 5)
largely exceeded that observed at 4°C (Fig. 2). Thus the
estimated number of LDL particles bound and taken up at 37°C
corresponds to about 10,000 per cell per hour, This, together
with the lesser degree of LDL inhibition by heparin at 37°C is
consistent with the formulation that mesangial cells at 37°C both
bind and internalize LDL. There also may be an increase in
non-specific binding at 37°C contributing to association of LDL
with the cells by a process that is not inhibited by heparin.
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Fig. 6. Uptake of the fluorescent probe Dil-LDL by mesangial cells. Mesangial cells grown on plastic slides were incubated with Dil-LDL (10 sgJ
ml) for 2 hours, washed and photographed under phase contrast (A) and fluorescence (B) microscopy. Note prominent perinuclear fluorescence
of all cells and absence of fluorescence over areas not covered by cells.
Uptake of fluorescent Dil-LDL
After a two hour incubation with the fluorescent-probe-
labeled Dil-LDL all mesangial cells showed prominent perinu-
clear fluorescence (Fig. 6). No fluorescence was observed over
areas not covered by cells. This is consistent with endocytosis
of Dil-LDL and delivery to lysosomes as described in fibro-
blasts [19]. It confirms our binding and uptake results for [1251]
LDL and also shows that all mesangial cells are capable of
uptake of LDL.
Effects of LDL on [3H] thymidine incorporation and
PGE2 production
The effect of different concentrations of LDL on mesangial
cell proliferation was examined by [3H] thymidine incorpora-
tion. This was studied after removal of fetal calf serum from the
medium for 24 hours in order to decrease down regulation of
LDL receptors [12]. Addition of LDL caused a biphasic effect
with modest stimulation of [3H] thymidine incorporation at 10
jg/ml of LDL and a progressive inhibition at LDL concentra-
tions of 100 to 500 g/ml (Fig. 7, Table 1). For comparison BSA
had no effect on [3H] thymidine incorporation at these concen-
trations. LDL also inhibited thymidine incorporation in the
presence of FCS. Addition of 10% FCS alone to mesangial cells
















Fig. 7. Effect of LDL on [3jJj thymidine incorporation by mesangial
cells. Thymidine incorporation into mesangial cells was determined in
the presence of increasing concentrations of LDL during 24 hours of
culture. Results represent [3H] thymidine incorporated per well on 96
well plates, and are means SEM of 3 experiments, each carried out in
quadruplicate.
(Table 2). Addition of 250 ig/ml of LDL to 10% FCS resulted in
a marked inhibition of [3H] thymidine incorporation by mesan-
gial cells (Table 2). The effect of high concentrations of LDL
10 50 100 250
B
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10 tg/ml 500 .tg/ml
CPM/well 4960 970 6470 1170 330 120
P value <0.01 <0.02
Mesangial cells were cultured in medium without fetal calf serum
overnight prior to addition of LDL and lII] thymidine; [3H] thymidine
incorporation was evaluated after the subsequent 24 hrs in culture as
described in Methods. Values represent means 5EM from five series of
experiments, each carried out in quadruplicate, P values refer to paired
comparison with the control values.
Table 2. Effect of fetal calf serum alone and in combination with
LDL on PH] thymidine incorporation into mesangial cells
Basal 10% FCS
10% FCS + LDL
250 jig/mI
CPM/well 6610 310 9440 50 2140 640
P value <0.02 <0.05
Details are in Table 1. Values represent means SEM of three series
of experiments, each carried out in quadruplicate. P value refers to
paired comparison with the basal values.
Table 3. Effect of LDL on PGE2 production by mesangial cells
Medium
only
pg/mI x 24 hrs
BSA LDL
10 jig/mI 10 jig/mI
BSA LDL











Mesangial cells grown in 24-well culture dishes were incubated with
medium only or with medium containing the additions indicated; POE2
content of the media was determined after 24 hours of incubation. For
details refer to Methods. Results are means 5EM for the number of
experiments indicated in brackets. P values refer to group comparison
by unpaired t-test with the values for the respective BSA controls.
could also be appreciated visually. Mesangial cell cultures
exposed to 250 and 500 jig/mi of LDL appeared altered under
phase contrast microscopy with rarefication of vacuolated cells
which exhibited thread-like cell extensions.
LDL has been shown to modestly increase prostaglandin
production by vascular smooth muscle cells and endothelial
cells [21, 22]. POE2 in turn may inhibit mesangial cell prolifer-
ation [23]. We therefore examined the effects of LDL both on
PGE2 production by mesangial cells and on NH] thymidine
incorporation in the presence of the prostaglandin synthesis
inhibitor meclofenamate. As shown in Table 3, LDL at 10 and
100 jig/mI increased PGE2 production by mesangial cells,
similar to the observations in vascular smooth muscle and
endothelial cells [21, 22]. Meclofenamate decreased PGE2 for-
mation to undetectable levels (not shown) but did not influence
the antiproliferative effect of LDL on mesangial cells (Table 4).
Thus LDL suppressed [3H] thymidine incorporation into
mesangial cells in a manner independent of prostagiandin
formation.
Table 4. Effect of LDL in the presence or absence of the
prostaglandin inhibitor mcclofcnamatc on t'i] thymidine




Control Meclo 250 jig/mI
CPM/well 3035 299 3095 395 300 59 298 64
P value NS <0.01 <0.01
Details are in Table I. Results are means SEM of 4 series of
experiments, each carried out in quadruplicate. Meclofenamate
(10-6 M) was present during the 24 hours of PH] thymidine incorpora-
tion. P values refer to comparison by unpaired t-test with the control
value.
Discussion
Our current studies of the interaction of LDL with cultured
rat mesangial cells indicate that these cells have specific LDL
receptors that have the binding characteristics of those de-
scribed in detail by Goldstein and Brown [12]. The evidence for
LDL receptors on mesangial cells is based on a number of
observations: Binding of LDL to mesangial cells at 4°C occurs
in a time- and concentration-dependent manner. The binding
curves show saturability with half maximal binding occurring at
approximately 5 jig/mi of LDL and an estimated number of 1000
LDL particles bound per mesangial cell. These numbers are
comparable to those observed in fibroblasts and vascular
smooth muscle cells [12]. Similarly, inhibition of LDL binding
by heparin is consistent with typical LDL receptor interactions.
Heparin has been shown to ionically interact with positive
charges on lysine residues of LDL and to compete with
negative charges on the LDL receptor, resulting in inhibition or
displacement of LDL binding 120]. The difference between 80%
inhibition of LDL binding by heparin at 4°C and only 40% at
37°C would be consistent with binding and uptake of LDL
occurring at 37°C. This is also supported by the uptake curves
of LDL at 37°C, which showed considerably more cell associ-
ated LDL and little saturability as compared to the LDL
binding at 4°C. The enhanced binding at 37°C would be ex-
plained by uptake of the LDL receptor complex and receptor
recycling with reappearance of the receptor on the cell mem-
brane after intracellular release of LDL, as demonstrated by
others [12]. It is also possible that there is an increased
non-specific component of LDL binding at 37°C.
Further evidence for uptake of LDL by mesangial cells was
obtained by use of the fluorescence labeled probe Dii-LDL [191.
Mesangial cells showed prominent perinuclear fluorescence
after two hour incubations with Dil-LDL, consistent with
lysosomal location as noted in fibroblasts [19]. These experi-
ments also exclude that a subpopulation of mesangial cells
could be responsible for the LDL binding and uptake, as all
mesangial cells examined showed fluorescence for Dil-LDL
(Fig. 6).
The consequences of LDL uptake by mesangial cells were
evaluated by determining cell proliferation, using [3H] thymi-
dine uptake into DNA, and by measuring POE2 generation.
LDL showed a biphasic effect on NH] thymidine incorporation
by mesangial cells. Low concentrations of LDL (10 p.g/ml)
enhanced PH] thymidine incorporation into DNA, while con-
centrations above 100 jsg/ml of LDL resulted in inhibition.
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Again these findings are highly reminiscent of those reported for
cultured endothelial and vascular smooth muscle cells [14—16].
The mechanism of the detrimental effects of high LDL concen-
trations on mesangial cells remains to be determined. It could
be related to excessive accumulation of LDL within mesangial
cells or perhaps to lipid peroxidation of LDL, which has been
proposed to contribute to LDL induced pathology [24]. We are
currently investigating the latter possibility.
LDL has been reported to slightly enhance prostaglandin
synthesis in cultured endothelial and vascular smooth muscle
cells [21, 22]. Prostaglandins in turn may inhibit mesangial cell
proliferation [23]. Our results show, however, that whereas
LDL moderately increased PGE2 synthesis by mesangial cells,
the effect of LDL on mesangial [3H] thymidine incorporation
persisted even during inhibition of prostaglandin synthesis, that
is, was independent of PGE2.
The demonstrated inhibitory effect of LDL on [3H] thymidine
incorporation is of interest as 100 to 500 pg/mI of LDL is well
within the physiological range of plasma concentration. It is
unknown, however, what the prevailing concentrations of LDL
would be for mesangial cells in vivo. The glomerular mesan-
gium is separated from the capillary blood stream only by a
fenestrated endothelium. The diameter of the endothelial fene-
strae is about 40 nm which, in the absence of an intervening
basement membrane, allows the passage of noncharged parti-
cles with diameters around 20 nm [25]. The mean diameter of
LDL particles is 20 nm, so that some LDL would flow through
the mesangial area. Other factors such as negative surface
charges of the endothelium and the LDL particles would,
however, considerably diminish LDL passage into the mesan-
gium. It is therefore reasonable to assume that LDL concentra-
tions of plasma percolating the mesangium are considerably less
than those in the glomerular capillaries and may well fall in the
range of LDL concentrations supporting mesangial growth. It is
interesting to speculate that in states of hyperlipidemia mesan-
gial cells would be exposed to higher levels of LDL, which
might then contribute to the pathological lesions noted in the
disease models of 5/6 nephrectomized rats [8], the obese Zucker
rat [9], cholesterol-fed guinea pigs [26] and chronic puromycin-
aminonucleoside nephrosis [10]. For example, overload of
mesangial cells by LDL particles could influence production
and metabolism of mesangial matrix and basement membrane
components, production of cytokines and mediators of inflam-
mation by mesangial cells, and even infiltration by macro-
phages. These considerations remain speculative, but can in
part be experimentally explored in vitro using cultured mesan-
gial cells. In combination with in vivo studies this could shed
light on the role of hyperlipidemia in the initiation and progres-
sion of glomerular disease.
Acknowledgments
We gratefully acknowledge of the secretarial support of Iris Baptiste.
This work was supported in part by NIH Grants AM22036, HL26817
and DK20541 and a grant in aid from the American Heart Association.
H. Holthofer was a recipient of a Public Health Service Fogarty
International Fellowship (1-F05-TWO-3744-0l) and A. Santiago a
recipient of a Public Health Service Fellowship (5 T 32 HL 07 83).
Reprint requests to Detlef Schlondorff, M.D., Albert Einstein College
of Medicine, 1300 Morris Park Avenue, Ullmann Building—Room 617,
Bronx, New York /0461, USA.
I. CHAN MK, VARGHESE Z, MOREHEAD JF: Lipid abnormalities in
uremia. Kidney mt 19:625—637, 1981
2. APPEL GB, BLUM CB, CHIEN S, KuNIs CL, AI'PEL AS: The
hyperlipidemia of the nephrotic syndrome. Relation to plasma
albumin concentration oncotic pressure and viscosity. N Engi J
Med 312:1544—1548, 1985
3. GITLIN D, CORNwELL DG, NAKASATO D, ONCLEY JL, HUGHES
WL, JANEWAY CA: Studies on the metabolism of plasma proteins
in the nephrotic syndrome II. The lipoproteins. (abstract) J Clin
Invest 37:172, 1958
4. MARSH JB, DRABKIN DL: Experimental reconstruction of meta-
bolic changes of lipid nephrosis: Key role of hepatic protein
synthesis in hyperlipidemia. (abstract) Metabolism 9:946, 1986
5. SHAPIRO RJ, ELAM R, WITz: Catabolism of LDL is altered in
experimental chronic renal failure. (abstract) Kidney mt 31:250,
1987
6. MOORHEAD JF, CHAN MK, VARGHESE Z: The role of abnormalities
of lipid metabolism in the progression of renal disease. Contemp Iss
Nephrol 14:133—148, 1986
7. DIAMOND JR, KARNOFSKY MJ: Focal and segmental glomerulo-
sclerosis: analogies to atherosclerosis. Kidney mt 33:917—924, 1988
8. KA5IsKE BL, O'DONNELL MP, GARVIS Wi, KEANE WF: Pharma-
cologic treatment of hyperlipidemia reduces glomerular injury in
the 5/6 nephrectomy model of chronic renal failure. Circ Res (in
press)
9. KASISKE BL, CLEARY MP, O'DONNELL MP, KEANE WE: Mecha-
nisms of glomerular injury in the obese Zucker rat. Kidney In! 33:
667—672, 1988
10. DIAMOND JR, KARNOV5KY MJ: Exacerbation of chronic aminonu-
cleoside nephrosis by dietary cholesterol supplementation. Kidney
mt 32:671—678, 1987
11. Ross R: The pathogenesis of atherosclerosis—an update. N Engl J
Med i:488—500, 1986
12. GOLDSTEIN JL, BROWN MS: The low-density lipoprotein pathway
and its relation to atherosclerosis. Ann Rev Biochem 46:897—930,
1977
13, WHEELER DC, ZARUBA J, SENIOR J, SCOBLE J, SWENY P. VARG-
HESE Z, MOREHEAD iF: Lipoprotein binding by cultured rat mesan-
gial cells. Proc of the Xth mt Congr of Nephrol (London) 523A,
1987
14. GosPoDARowlcz D, HIRABAYASHI K, GIGUERE L, TAUBER JP
Factors controlling the proliferative rate, final cell density, and life
span of bovine vascular smooth muscle cells in culture. Cell Biol 89:
568—578, 1981
15. TAUBER JP, CHENG J, GOSPODAROWICZ D: Effect of high and low
density lipoproteins on proliferation of cultured bovine vascular
endothelial cells. J Clin Invest 66:696—708, 1980
16. TAUBERJP, GOLDMINZ D, VLODAVSKY I, GOSPODAROWICZ D: The
interaction of high-density lipoprotein with cultured cells of bovine
vascular endothelium. J Biochem ll'9:317—325, 1981
17. SCHLONDORFFD, DECANDIDO S, SATRIANO JA: Angiotensin II
stimulates phospholipases C and A2 in cultured rat mesangial cells.
Am J Physiol 253:Cl l3—Cl20, 1987
18. BAR-ON H, ROHEIM PS, EDER HA: Serum lipoproteins and apo-
lipoproteins in rats with streptozotocin induced diabetes. J Clin
Invest 57:714—721, 1976
19. PITA5 RE, INNERARITY TL, WEINSTEIN iN, MAHLEY RW: Ace-
toacetylated lipoproteins used to distinguish fibroblasts from mac-
rophages in vitro by fluorescence microscopy. Arteriosclerosis 1:
177—185, 1981
20. GOLDSTEIN JL, BASU SK, BRUNSCHEDE GY, BROWN MS: Release
of low density lipoprotein from its cell suface receptor by sulfated
glycosaminoglycans. Cell 7:85—95, 1976
21. POMERANTZ KB, TALL AR, FEINMARK Si, CANNON PJ: Stimula-
tion of vascular smooth muscle cell prostacylin and prostaglandin
E2 synthesis by plasma high and low density lipoproteins. Circ Res
54:554—565, 1984
22. FLEISHER LN, TALL AR, WITTE LD, MILLER RW, CANNON PJ:
Stimulation of arterial endothelial cell prostacyclin synthesis by
high density lipoproteins. J Biol Chem 257:6653—6655, 1982
References
1174 Wasserman et a!: Low density lipoprotein
23. HOMMA T, Ici-HKAwA I, HoovER RI: Prostaglandins of mesangial
origin inhibit mesangial cell proliferation and matrix synthesis.
(abstract) Kidney mt 33:268A, 1988
24. STEINDRECHER UP, PARTHASARATHY S. LEAKE DS, WITZTUM JL,
STEINBRO D: Modification of low density lipoprotein by endothe-
hal cells involves lipid peroxidation and degradation of low density
lipoprotein phospholipids. Proc Nat! Acad Sci USA 81:3883—3887,
1984
25. LA-I-TA H, FLIGIEL S: Mesangial fenestrations, sieving, filtration
and flow. Lab Invest 52:591—598, 1985
26. FRENCH SW, YARANAKA W: Dietary induced glomerosclerosis in
the guinea pig. Arch Patho! 83:204—210, 1967
